HIV/丙型肝炎病毒药物相互作用患者的管理：护士和执业护士指南。
Management of the Patient With HIV/Hepatitis C Drug Interactions: A Guide for Nurses and Nurse Practitioners.
出版信息
J Assoc Nurses AIDS Care. 2020 Mar-Apr;31(2):241-248. doi: 10.1097/JNC.0000000000000144.
Abstract
Approximately one third of patients coinfected with HIV and hepatitis C virus (HCV) who initiate direct-acting antivirals (DAAs) for HCV treatment may have to switch antiretroviral therapy (ART) because of drug interactions. ART switches can negatively affect quality of life, increase HIV symptom burden, and delay HCV therapy. Approaches to identify ART/DAA drug interactions that minimize the impact of switching ART are urgently needed. Nurses can lead the way in addressing this new and major need. We provide a guide for registered nurses and nurse practitioners who care for patients coinfected with HIV and HCV to identify HIV/HCV drug interactions and manage ART/DAA coadministration when needed.
摘要
约三分之一同时感染艾滋病毒和丙型肝炎病毒 (HCV) 的患者在开始接受直接作用抗病毒药物 (DAA) 治疗 HCV 时，可能由于药物相互作用而不得不更换抗逆转录病毒治疗 (ART)。ART 转换会对生活质量产生负面影响，增加 HIV 症状负担，并延迟 HCV 治疗。因此，迫切需要寻找识别 ART/DAA 药物相互作用的方法，以最大程度地减少更换 ART 的影响。护士可以在解决这一新的重大需求方面发挥主导作用。我们为护理同时感染 HIV 和 HCV 的患者的注册护士和执业护士提供了一份指南，以帮助他们识别 HIV/HCV 药物相互作用，并在需要时管理 ART/DAA 联合用药。
相似文献
1
Management of the Patient With HIV/Hepatitis C Drug Interactions: A Guide for Nurses and Nurse Practitioners.HIV/丙型肝炎病毒药物相互作用患者的管理：护士和执业护士指南。
J Assoc Nurses AIDS Care. 2020 Mar-Apr;31(2):241-248. doi: 10.1097/JNC.0000000000000144.
2
Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient.关注药物相互作用：在 HIV 阳性患者中用直接作用抗病毒药物治疗丙型肝炎病毒感染的挑战。
Curr Opin Infect Dis. 2013 Feb;26(1):50-7. doi: 10.1097/QCO.0b013e32835c2027.
3
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients.大型HIV/HCV合并感染患者队列中抗逆转录病毒药物与HCV直接作用抗病毒药物之间的药物相互作用潜力
PLoS One. 2015 Oct 21;10(10):e0141164. doi: 10.1371/journal.pone.0141164. eCollection 2015.
4
Treatment of chronic HCV genotype 1 coinfection.慢性丙型肝炎病毒1型合并感染的治疗。
Curr HIV/AIDS Rep. 2015 Sep;12(3):326-35. doi: 10.1007/s11904-015-0278-4.
5
Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.直接作用抗病毒药物治疗 HIV/HCV 合并感染患者的最佳疗法。
Liver Int. 2015 Jan;35 Suppl 1:51-5. doi: 10.1111/liv.12721.
6
Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors.丙型肝炎抗病毒药物奥比他韦、帕利瑞韦/利托那韦和达沙布韦与HIV-1蛋白酶抑制剂之间的药物相互作用评估。
Clin Infect Dis. 2016 Apr 15;62(8):972-9. doi: 10.1093/cid/civ1213. Epub 2016 Jan 5.
7
Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.荷兰 HIV/丙型肝炎病毒合并感染患者中直接作用抗病毒药物药物相互作用的管理：足够但不完美。
HIV Med. 2018 Mar;19(3):216-226. doi: 10.1111/hiv.12570. Epub 2017 Dec 1.
8
Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.直接作用抗病毒药物治疗丙型肝炎和抗逆转录病毒药物：药物相互作用的潜力。
Curr Opin HIV AIDS. 2011 Nov;6(6):514-26. doi: 10.1097/COH.0b013e32834b54dc.
9
Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals.大多数艾滋病毒/丙型肝炎患者需要更换抗逆转录病毒疗法以配合直接抗病毒药物。
AIDS Patient Care STDS. 2015 Jul;29(7):379-83. doi: 10.1089/apc.2015.0004. Epub 2015 Jun 11.
10
Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world.合并感染患者慢性丙型肝炎治疗在现实世界中的有效性和安全性。
Int J Clin Pharm. 2018 Jun;40(3):608-616. doi: 10.1007/s11096-018-0621-0. Epub 2018 Mar 20.
本文引用的文献
1
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.《2019年丙型肝炎指南更新：美国肝病研究协会-美国传染病学会关于丙型肝炎病毒感染检测、管理及治疗的建议》
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
2
Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected Patients.简短报告：老年HIV/HCV合并感染患者在开始使用直接抗病毒药物时，更换抗逆转录病毒治疗方案或联合用药的需求较高。
J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):193-199. doi: 10.1097/QAI.0000000000001488.
3
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.在HIV/HCV合并感染患者的系统筛查项目中进行无创肝纤维化评估及启动丙型肝炎病毒治疗
Wien Klin Wochenschr. 2018 Feb;130(3-4):105-114. doi: 10.1007/s00508-017-1231-x. Epub 2017 Jul 25.
4
Economic Outcomes of First-Line Regimen Switching Among Stable Patients with HIV.一线方案转换对 HIV 稳定期患者的经济学结局影响
J Manag Care Spec Pharm. 2017 Jul;23(7):725-734. doi: 10.18553/jmcp.2017.16403. Epub 2017 Jun 5.
5
High hepatitis C cure rates among black and nonblack human immunodeficiency virus-infected adults in an urban center.城市中心感染人类免疫缺陷病毒的黑人和非黑人成年人中丙型肝炎的高治愈率
Hepatology. 2017 Nov;66(5):1402-1412. doi: 10.1002/hep.29308. Epub 2017 Oct 11.
6
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.索磷布韦和维帕他韦治疗人类免疫缺陷病毒 1 型合并丙型肝炎病毒感染患者：一项开放标签、3 期研究。
Clin Infect Dis. 2017 Jul 1;65(1):6-12. doi: 10.1093/cid/cix260.
7
Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis.丙型肝炎病毒获得持续病毒学应答后晚期复发或再感染的风险：一项系统评价和荟萃分析。
Clin Infect Dis. 2016 Mar 15;62(6):683-694. doi: 10.1093/cid/civ948. Epub 2016 Jan 19.
8
Treating Hepatitis C in a Ryan White-Funded HIV Clinic: Has the Treatment Uptake Improved in the Interferon-Free Directly Active Antiviral Era?在由瑞安·怀特基金资助的艾滋病诊所治疗丙型肝炎：在无干扰素直接抗病毒时代，治疗接受率是否有所提高？
AIDS Patient Care STDS. 2016 Feb;30(2):51-5. doi: 10.1089/apc.2015.0222. Epub 2016 Jan 8.
9
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients.大型HIV/HCV合并感染患者队列中抗逆转录病毒药物与HCV直接作用抗病毒药物之间的药物相互作用潜力
PLoS One. 2015 Oct 21;10(10):e0141164. doi: 10.1371/journal.pone.0141164. eCollection 2015.
10
Project P.E.A.C.H. (Pathway and Education Toward Adherence and Completion in Hepatitis C Therapy): A Nurse-Driven Evidence-Based Protocol.桃子计划（丙型肝炎治疗的依从性与完成率途径及教育）：一项由护士主导的循证方案
Gastroenterol Nurs. 2015 Sep-Oct;38(5):369-78. doi: 10.1097/SGA.0000000000000166.
Zotero 插件